← brief for 2026-09-23 · Slowing decline
New pharmacologic and interventional horizons in hypertension and nondialysis chronic kidney disease: bridging innovation and clinical translation.
Key takeaways
This is a review of new blood pressure drugs for people with kidney disease. It talks about what is coming, but it does not report new trial results. It is a discussion, not a study.
Who did this work
Damianaki A · Iliakis P · Vakka A · Stambolliu E · Sakalidis A · Dimitriadis K · Petras D · Tsioufis K
Source
Article · PubMed, the drug frontier · 2026 Sep 18
https://pubmed.ncbi.nlm.nih.gov/42775984/